ISPOR Europe 2026
Talk
Addressing the Challenges in Rare Disease Methods
Tue, Nov 10, 2026 · 4:45–5:45 PM CET Theater 1, Hall X1-X4, Level -2, Austria Center Vienna
About this session
This session highlights multiple areas of challenge in generating robust evidence for value assessment in rare diseases and provides examples of how these challenges play out in varying access contexts (conditional access agreements, joint clinical assessment and national-level HTA).
